Resveratrol Extract Powder (1 lb)

Our Price: $119.99


Add to Cart:      

Add to Wish List
Use your smartphone camera to scan this image and load this product on your mobile phones browser.



The secret to anti-aging lies with trans-resveratrol, the active form of Resveratrol polyphenols. In its pure form, trans-resveratrol activates the SIRT1 longevity gene and enhances cellular productivity. Our natural resveratrol is extracted from Polygonum Cuspidatum Root yielding 50% trans-resveratrol.

Some possible benefits of our Natural Resveratrol Extract Powder may include:

● Promoting a healthy heart
● Powerful cardioprotective properties
● Helpful to ward off melanoma
● Boosting cellular energy output


Suggested Use: Take 1/10 teaspoon (200 mg) with food once daily.

Botanical Name: Polygonum cuspidatum Extract

Ingredients: Resveratrol Extract.

Other Names: Japanese knotweed, fleeceflower, Himalayan fleece vine, monkeyweed, monkey fungus, Hancock's curse, elephant ears, pea shooters, donkey rhubarb, sally rhubarb, Japanese bamboo, American bamboo, Mexican bamboo, Huzhang, tiger stick, and itadori

Origin: Grown and extracted in China. Packaged with care in Florida, USA.

Z Natural Foods strives to offer the highest quality organically grown, raw, vegan, gluten free, non-GMO products available and exclusively uses low temperature drying techniques to preserve all the vital enzymes and nutrients. Our Resveratrol Extract Powder passes our strict quality assurance which includes testing for botanical identity, heavy metals, chemicals and microbiological contaminants. ZNaturalFoods.com offers Resveratrol Extract Powder packaged in airtight stand-up, resealable foil pouches for optimum freshness. Once opened, just push the air out of the pouch before resealing it in order to preserve maximum potency. Keep your Resveratrol Extract Powder in a cool, dark, dry place.

References:

1. Camont, L; Cottart, C; Rhayem, Y; Nivetantoine, V; Djelidi, R; Collin, F; Beaudeux, J; Bonnefontrousselot, D (2009). "Simple spectrophotometric assessment of the trans-/cis-resveratrol ratio in aqueous solutions". Analytica Chimica Acta 634 (1): 121–8. doi:10.1016/j.aca.2008.12.003. PMID 19154820.

2. Resveratrol MSDS on Fisher Scientific website

3. Resveratrol MSDS on www.sigmaaldrich.com

4. Bechmann, LP; Zahn, D; Gieseler, RK; Fingas, CD; Marquitan, G; Jochum, C; Gerken, G; Friedman, SL et al. (2009). "Resveratrol amplifies profibrogenic effects of free fatty acids on human hepatic stellate cells". Hepatology research : the official journal of the Japan Society of Hepatology 39 (6): 601–8. doi:10.1111/j.1872-034X.2008.00485.x. PMC 2893585. PMID 19207580.

5. Bass TM, Weinkove D, Houthoofd K, Gems D, Partridge L (October 2007). "Effects of resveratrol on lifespan in Drosophila melanogaster and Caenorhabditis elegans". Mech. Ageing Dev. 128 (10): 546–52. doi:10.1016/j.mad.2007.07.007. PMID 17875315.

6. "Micronutrient Information Center: Resveratrol". Linus Pauling Institute at Oregon State University. Retrieved 2012-01-13.

7. Elliott PJ, Jirousek M (April 2008). "Sirtuins: novel targets for metabolic disease". Curr Opin Investig Drugs 9 (4): 371–8. PMID 18393104.

8. "Sirtris Announces Positive Results with Proprietary Version of Resveratrol, SRT501, in a Phase 1b Type 2 Diabetes Clinical Study - Drugs.com MedNews". Press Release. Drugs.com. 2008-01-07. Retrieved 2012-02-22.

9. "Pharma seeks genetic clues to healthy aging". Reuters. 6 April 2010.

10. The Connecticut Post, "Selling resveratrol: Wonder drug or snake oil?," 08/04/2009, by Melissa Healy for the Los Angeles Times news service

11. Gehm BD, McAndrews JM, Chien PY, Jameson JL (December 1997). "Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor". Proc. Natl. Acad. Sci. U.S.A. 94 (25): 14138–43. doi:10.1073/pnas.94.25.14138. PMC 28446. PMID 9391166.

12. Baur JA, Sinclair DA (June 2006). "Therapeutic potential of resveratrol: the in vivo evidence". Nat Rev Drug Discov 5 (6): 493–506. doi:10.1038/nrd2060. PMID 16732220.

13. Farina A, Ferranti C, Marra C (March 2006). "An improved synthesis of resveratrol". Nat. Prod. Res. 20 (3): 247–52. doi:10.1080/14786410500059532. PMID 16401555.

14. Trantas E, Panopoulos N, Ververidis F (November 2009). "Metabolic engineering of the complete pathway leading to heterologous biosynthesis of various flavonoids and stilbenoids in Saccharomyces cerevisiae". Metab. Eng. 11 (6): 355–66. doi:10.1016/j.ymben.2009.07.004. PMID 19631278.

15. Wang, H.; Liu, L.; Guo, Y.-X.; Dong, Y.-S.; Zhang, D.-J.; Xiu, Z.-L. (2007). "Biotransformation of piceid in Polygonum cuspidatum to resveratrol by Aspergillus oryzae". Applied Microbiology and Biotechnology 75 (4): 763–8. doi:10.1007/s00253-007-0874-3. PMID 17333175.

16. Stilbene derivatives from Gnetum cleistostachyum. Chun-Suo Yao, Mao Lin, Xin Liu and Ying-Hong Wang, Journal of Asian Natural Products Research, 2005, Volume 7, Issue 2, pages 131-137, doi:10.1080/10286020310001625102, PubMed

17. Resveratrol, a new phenolic compound, from Veratrum grandiflorum. M Takaoka, Journal of the Chemical Society of Japan, 1939, volume 60, pages 1090-1100 (abstract)

18. Schröder, Joachim (March 6, 2010). "Discovery of resveratrol". Resveratrol.[self-published source?]

19. Howitz KT, Bitterman KJ, Cohen HY, Lamming DW, Lavu S, Wood JG, Zipkin RE, Chung P, Kisielewski A, Zhang LL, Scherer B, Sinclair DA (September 2003). "Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan". Nature 425 (6954): 191–6. doi:10.1038/nature01960. PMID 12939617.

20. Wood JG, Rogina B, Lavu S, Howitz K, Helfand SL, Tatar M, Sinclair D (August 2004). "Sirtuin activators mimic caloric restriction and delay ageing in metazoans". Nature 430 (7000): 686–9. doi:10.1038/nature02789. PMID 15254550.

21. Gruber J, Tang SY, Halliwell B (April 2007). "Evidence for a trade-off between survival and fitness caused by resveratrol treatment of Caenorhabditis elegans". Ann. N. Y. Acad. Sci. 1100: 530–42. doi:10.1196/annals.1395.059. PMID 17460219.

22. Valenzano DR, Terzibasi E, Genade T, Cattaneo A, Domenici L, Cellerino A (February 2006). "Resveratrol prolongs lifespan and retards the onset of age-related markers in a short-lived vertebrate". Curr. Biol. 16 (3): 296–300. doi:10.1016/j.cub.2005.12.038. PMID 16461283.

23. Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, Prabhu VV, Allard JS, Lopez-Lluch G, Lewis K, Pistell PJ, Poosala S, Becker KG, Boss O, Gwinn D, Wang M, Ramaswamy S, Fishbein KW, Spencer RG, Lakatta EG, Le Couteur D, Shaw RJ, Navas P, Puigserver P, Ingram DK, de Cabo R, Sinclair DA (November 2006). "Resveratrol improves health and survival of mice on a high-calorie diet". Nature 444 (7117): 337–42. doi:10.1038/nature05354. PMID 17086191.

24. Pearson KJ, Baur JA, Lewis KN, Peshkin L, Price NL, Labinskyy N, Swindell WR, Kamara D, Minor RK, Perez E, Jamieson HA, Zhang Y, Dunn SR, Sharma K, Pleshko N, Woollett LA, Csiszar A, Ikeno Y, Le Couteur D, Elliott PJ, Becker KG, Navas P, Ingram DK, Wolf NS, Ungvari Z, Sinclair DA, de Cabo R (August 2008). "Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span". Cell Metab. 8 (2): 157–68. doi:10.1016/j.cmet.2008.06.011. PMC 2538685. PMID 18599363.

25. Miller RA, Harrison DE, Astle CM, Floyd RA, Flurkey K, Hensley KL, Javors MA, Leeuwenburgh C, Nelson JF, Ongini E, Nadon NL, Warner HR, Strong R (August 2007). "An Aging Interventions Testing Program: study design and interim report". Aging Cell 6 (4): 565–75. doi:10.1111/j.1474-9726.2007.00311.x. PMID 17578509.

26. Miller RA, Harrison DE, Astle CM, Baur JA, Boyd AR, de Cabo R, Fernandez E, Flurkey K, Javors MA, Nelson JF, Orihuela CJ, Pletcher S, Sharp ZD, Sinclair D, Starnes JW, Wilkinson JE, Nadon NL, Strong R (February 2011). "Rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous mice". J. Gerontol. A Biol. Sci. Med. Sci. 66 (2): 191–201. doi:10.1093/gerona/glq178. PMC 3021372. PMID 20974732.

27. Kaeberlein, Matt; McDonagh, Thomas; Heltweg, Birgit; Hixon, Jeffrey; Westman, Eric A.; Caldwell, Seth D.; Napper, Andrew; Curtis, Rory; DiStefano, Peter S.; Fields, Stanley; Bedalov, Antonio; Kennedy, Brian K. (April 2005). "Substrate-specific activation of sirtuins by resveratrol". Journal of Biological Chemistry 208 (17): 17038–17045. doi:10.1074/jbc.M500655200. PMID 15684413. Retrieved November 14, 2012.

28. Wade, Nicholas (November 16, 2006). "Red Wine Ingredient Increases Endurance, Study Shows". New York Times.

29. Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F, Messadeq N, Milne J, Lambert P, Elliott P, Geny B, Laakso M, Puigserver P, Auwerx J (December 2006). "Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha". Cell 127 (6): 1109–22. doi:10.1016/j.cell.2006.11.013. PMID 17112576.

30. "'Longevity gene' may be dead end: study". The Raw Story. Agence France-Presse. September 12, 2011.

31. Ledford, Heidi (2011). "Longevity genes challenged". Nature. doi:10.1038/news.2011.549.

32. Viswanathan M, Guarente L (September 2011). "Regulation of Caenorhabditis elegans lifespan by sir-2.1 transgenes". Nature 477 (7365): E1–2. doi:10.1038/nature10440. PMID 21938026.

33.Lombard DB, Pletcher SD, Cantó C, Auwerx J (September 2011). "Ageing: longevity hits a roadblock". Nature 477 (7365): 410–1. doi:10.1038/477410a. PMID 21938058.

34. Hubbard, Basil P.; Ana P. Gomes, Han Dai, Jun Li, April W. Case, Thomas Considine, Thomas V. Riera, Jessica E. Lee, Sook Yen E, Dudley W. Lamming, Bradley L. Pentelute, Eli R. Schuman, Linda A. Stevens, Alvin J. Y. Ling, Sean M. Armour, Shaday Michan, Huizhen Zhao, Yong Jiang, Sharon M. Sweitzer, Charles A. Blum, Jeremy S. Disch, Pui Yee Ng, Konrad T. Howitz, Anabela P. Rolo, Yoshitomo Hamuro, Joel Moss, Robert B. Perni, James L. Ellis, George P. Vlasuk, David A. Sinclair (2013). "Evidence for a Common Mechanism of SIRT1 Regulation by Allosteric Activators". Science. doi:10.1126/science.1231097.

35. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, Fong HH, Farnsworth NR, Kinghorn AD, Mehta RG, Moon RC, Pezzuto JM (January 1997). "Cancer chemopreventive activity of resveratrol, a natural product derived from grapes". Science 275 (5297): 218–20. doi:10.1126/science.275.5297.218. PMID 8985016.

36. Lin, KH; Hsiao, G; Shih, CM; Chou, DS; Sheu, JR (2009). "Mechanisms of resveratrol-induced platelet apoptosis". Cardiovascular research 83 (3): 575–85. doi:10.1093/cvr/cvp139. PMID 19423619.

37. Wang Z, Huang Y, Zou J, Cao K, Xu Y, Wu JM (January 2002). "Effects of red wine and wine polyphenol resveratrol on platelet aggregation in vivo and in vitro". Int. J. Mol. Med. 9 (1): 77–9. PMID 11745001. edit

38. Zou J, Huang Y, Chen Q, Wang N, Cao K, Hsieh TC, Wu JM (October 1999). "Suppression of mitogenesis and regulation of cell cycle traverse by resveratrol in cultured smooth muscle cells". Int. J. Oncol. 15 (4): 647–51. PMID 10493944. edit

39. Brito PM, Devillard R, Nègre-Salvayre A, Almeida LM, Dinis TC, Salvayre R, Augé N (July 2009). "Resveratrol inhibits the mTOR mitogenic signaling evoked by oxidized LDL in smooth muscle cells". Atherosclerosis 205 (1): 126–34. doi:10.1016/j.atherosclerosis.2008.11.011. PMID 19108833. edit

40. Athar M, Back JH, Tang X, Kim KH, Kopelovich L, Bickers DR, Kim AL (November 2007). "Resveratrol: a review of preclinical studies for human cancer prevention". Toxicol. Appl. Pharmacol. 224 (3): 274–83. doi:10.1016/j.taap.2006.12.025. PMC 2083123. PMID 17306316.

41. Resveratrol. From Clinicaltrials.gov. Retrieved August 15, 2008.

42. Boocock DJ, Faust GE, Patel KR, Schinas AM, Brown VA, Ducharme MP, Booth TD, Crowell JA, Perloff M, Gescher AJ, Steward WP, Brenner DE (June 2007). "Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent". Cancer Epidemiol. Biomarkers Prev. 16 (6): 1246–52. doi:10.1158/1055-9965.EPI-07-0022. PMID 17548692.

43. Niles RM, Cook CP, Meadows GG, Fu YM, McLaughlin JL, Rankin GO (October 2006). "Resveratrol is rapidly metabolized in athymic (nu/nu) mice and does not inhibit human melanoma xenograft tumor growth". J. Nutr. 136 (10): 2542–6. PMC 1612582. PMID 16988123.

44. Wenzel E, Soldo T, Erbersdobler H, Somoza V (May 2005). "Bioactivity and metabolism of trans-resveratrol orally administered to Wistar rats". Mol Nutr Food Res 49 (5): 482–94. doi:10.1002/mnfr.200500003. PMID 15779067.

45. Li ZG, Hong T, Shimada Y, Komoto I, Kawabe A, Ding Y, Kaganoi J, Hashimoto Y, Imamura M (September 2002). "Suppression of N-nitrosomethylbenzylamine (NMBA)-induced esophageal tumorigenesis in F344 rats by resveratrol". Carcinogenesis 23 (9): 1531–6. doi:10.1093/carcin/23.9.1531. PMID 12189197.

46. Gao X, Xu YX, Divine G, Janakiraman N, Chapman RA, Gautam SC (July 2002). "Disparate in vitro and in vivo antileukemic effects of resveratrol, a natural polyphenolic compound found in grapes". J. Nutr. 132 (7): 2076–81. PMID 12097696.

47. Kimura Y, Okuda H (June 2001). "Resveratrol isolated from Polygonum cuspidatum root prevents tumor growth and metastasis to lung and tumor-induced neovascularization in Lewis lung carcinoma-bearing mice". J. Nutr. 131 (6): 1844–9. PMID 11385077.

48. Barger JL, Kayo T, Vann JM, Arias EB, Wang J, Hacker TA, Wang Y, Raederstorff D, Morrow JD, Leeuwenburgh C, Allison DB, Saupe KW, Cartee GD, Weindruch R, Prolla TA (2008). "A low dose of dietary resveratrol partially mimics caloric restriction and retards aging parameters in mice". In Tomé, Daniel. PLoS ONE 3 (6): e2264. doi:10.1371/journal.pone.0002264. PMC 2386967. PMID 18523577.

49. Szmitko PE, Verma S (January 2005). "Cardiology patient pages. Red wine and your heart". Circulation 111 (2): e10–1. doi:10.1161/01.CIR.0000151608.29217.62. PMID 15657377.

50. Ferrières J (January 2004). "The French paradox: lessons for other countries". Heart 90 (1): 107–11. doi:10.1136/heart.90.1.107. PMC 1768013. PMID 14676260.

51. Simini B (January 2000). "Serge Renaud: from French paradox to Cretan miracle". Lancet 355 (9197): 48. doi:10.1016/S0140-6736(05)71990-5. PMID 10615898.

52. Renaud S, de Lorgeril M (June 1992). "Wine, alcohol, platelets, and the French paradox for coronary heart disease". Lancet 339 (8808): 1523–6. doi:10.1016/0140-6736(92)91277-F. PMID 1351198.

53. Kopp P (June 1998). "Resveratrol, a phytoestrogen found in red wine. A possible explanation for the conundrum of the 'French paradox'?". Eur. J. Endocrinol. 138 (6): 619–20. doi:10.1530/eje.0.1380619. PMID 9678525.

54. Ferrero ME, Bertelli AE, Fulgenzi A, Pellegatta F, Corsi MM, Bonfrate M, Ferrara F, De Caterina R, Giovannini L, Bertelli A (December 1998). "Activity in vitro of resveratrol on granulocyte and monocyte adhesion to endothelium". Am. J. Clin. Nutr. 68 (6): 1208–14. PMID 9846848.

55. Rotondo S, Rajtar G, Manarini S, Celardo A, Rotillo D, de Gaetano G, Evangelista V, Cerletti C (April 1998). "Effect of trans-resveratrol, a natural polyphenolic compound, on human polymorphonuclear leukocyte function". Br. J. Pharmacol. 123 (8): 1691–9. doi:10.1038/sj.bjp.0701784. PMC 1565338. PMID 9605577.

56. Haider UG, Roos TU, Kontaridis MI, Neel BG, Sorescu D, Griendling KK, Vollmar AM, Dirsch VM (July 2005). "Resveratrol inhibits angiotensin II- and epidermal growth factor-mediated Akt activation: role of Gab1 and Shp2". Mol. Pharmacol. 68 (1): 41–8. doi:10.1124/mol.104.005421. PMID 15849355.

57. Wang Z, Chen Y, Labinskyy N, Hsieh TC, Ungvari Z, Wu JM (July 2006). "Regulation of proliferation and gene expression in cultured human aortic smooth muscle cells by resveratrol and standardized grape extracts". Biochem. Biophys. Res. Commun. 346 (1): 367–76. doi:10.1016/j.bbrc.2006.05.156. PMID 16759640.

58. Poussier B, Cordova AC, Becquemin JP, Sumpio BE (December 2005). "Resveratrol inhibits vascular smooth muscle cell proliferation and induces apoptosis". J. Vasc. Surg. 42 (6): 1190–7. doi:10.1016/j.jvs.2005.08.014. PMID 16376213.

59. Kurin E, Atanasov AG, Donath O, Heiss EH, Dirsch VM, Nagy M. Synergy study of the inhibitory potential of red wine polyphenols on vascular smooth muscle cell proliferation. Planta Med. 2012 May;78(8):772-8. doi: 10.1055/s-0031-1298440.Epub 2012 Apr 12. PubMed PMID: 22499559. http://www.ncbi.nlm.nih.gov/pubmed/22499559

60. Duffy SJ, Vita JA (February 2003). "Effects of phenolics on vascular endothelial function". Curr. Opin. Lipidol. 14 (1): 21–7. doi:10.1097/01.mol.0000052857.26236.f2. PMID 12544657.

61. Wallerath T, Deckert G, Ternes T, Anderson H, Li H, Witte K, Förstermann U (September 2002). "Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase". Circulation 106 (13): 1652–8. doi:10.1161/01.CIR.0000029925.18593.5C. PMID 12270858.

62. Chen CK, Pace-Asciak CR (March 1996). "Vasorelaxing activity of resveratrol and quercetin in isolated rat aorta". Gen. Pharmacol. 27 (2): 363–6. doi:10.1016/0306-3623(95)02001-2. PMID 8919657.

63. Olas B, Wachowicz B (August 2005). "Resveratrol, a phenolic antioxidant with effects on blood platelet functions". Platelets 16 (5): 251–60. doi:10.1080/09537100400020591. PMID 16011975.

64. Stef G, Csiszar A, Lerea K, Ungvari Z, Veress G (August 2006). "Resveratrol inhibits aggregation of platelets from high-risk cardiac patients with aspirin resistance". J. Cardiovasc. Pharmacol. 48 (2): 1–5. doi:10.1097/01.fjc.0000238592.67191.ab. PMID 16954814.

65. Wang Z, Zou J, Huang Y, Cao K, Xu Y, Wu JM (March 2002). "Effect of resveratrol on platelet aggregation in vivo and in vitro". Chin. Med. J. 115 (3): 378–80. PMID 11940369.

66. The red wine phenolicstrans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: Implications for protection against coronary heart disease. Cecil R. Pace-Asciak, Susan Hahn, Eleftherios P. Diamandis, George Soleas and David M. Goldberg, Clinica Chimica Acta, 31 March 1995, Volume 235, Issue 2, Pages 207–219, doi:10.1016/0009-8981(95)06045-1

67. Frémont L, Belguendouz L, Delpal S (1999). "Antioxidant activity of resveratrol and alcohol-free wine polyphenols related to LDL oxidation and polyunsaturated fatty acids". Life Sci. 64 (26): 2511–21. doi:10.1016/S0024-3205(99)00209-X. PMID 10403511.

68. Ungvari Z, Orosz Z, Rivera A, Labinskyy N, Xiangmin Z, Olson S, Podlutsky A, Csiszar A (May 2007). "Resveratrol increases vascular oxidative stress resistance". Am. J. Physiol. Heart Circ. Physiol. 292 (5): H2417–24. doi:10.1152/ajpheart.01258.2006. PMID 17220179.

69. Das DK, Maulik N (February 2006). "Resveratrol in cardioprotection: a therapeutic promise of alternative medicine". Mol. Interv. 6 (1): 36–47. doi:10.1124/mi.6.1.7. PMID 16507749.

70. Investigation Finds UConn Professor Fabricated Research - Work Focused On Resveratrol, Chemical In Red Wine Hartford Courant, January 11, 2012

71. Retraction Watch

72. Lamont KT, Somers S, Lacerda L, Opie LH, Lecour S (May 2011). "Is red wine a SAFE sip away from cardioprotection? Mechanisms involved in resveratrol- and melatonin-induced cardioprotection". J. Pineal Res. 50 (4): 374–80. doi:10.1111/j.1600-079X.2010.00853.x. PMID 21342247.

73. Su HC, Hung LM, Chen JK (June 2006). "Resveratrol, a red wine antioxidant, possesses an insulin-like effect in streptozotocin-induced diabetic rats". Am. J. Physiol. Endocrinol. Metab. 290 (6): E1339–46. doi:10.1152/ajpendo.00487.2005. PMID 16434553.

74. Deng JY, Hsieh PS, Huang JP, Lu LS, Hung LM (July 2008). "Activation of estrogen receptor is crucial for resveratrol-stimulating muscular glucose uptake via both insulin-dependent and -independent pathways". Diabetes 57 (7): 1814–23. doi:10.2337/db07-1750. PMC 2453636. PMID 18426865.

75. Palsamy P, Subramanian S (November 2008). "Resveratrol, a natural phytoalexin, normalizes hyperglycemia in streptozotocin-nicotinamide induced experimental diabetic rats". Biomed. Pharmacother. 62 (9): 598–605. doi:10.1016/j.biopha.2008.06.037. PMID 18675532.

76. Sharma S, Anjaneyulu M, Kulkarni SK, Chopra K (2006). "Resveratrol, a polyphenolic phytoalexin, attenuates diabetic nephropathy in rats". Pharmacology 76 (2): 69–75. doi:10.1159/000089720. PMID 16286809.

77. Schmatz R, Mazzanti CM, Spanevello R, Stefanello N, Gutierres J, Corrêa M, da Rosa MM, Rubin MA, Chitolina Schetinger MR, Morsch VM (May 2009). "Resveratrol prevents memory deficits and the increase in acetylcholinesterase activity in streptozotocin-induced diabetic rats". Eur. J. Pharmacol. 610 (1–3): 42–8. doi:10.1016/j.ejphar.2009.03.032. PMID 19303406.

78. Penumathsa SV, Thirunavukkarasu M, Zhan L, Maulik G, Menon VP, Bagchi D, Maulik N (December 2008). "Resveratrol enhances GLUT-4 translocation to the caveolar lipid raft fractions through AMPK/Akt/eNOS signalling pathway in diabetic myocardium". J. Cell. Mol. Med. 12 (6A): 2350–61. doi:10.1111/j.1582-4934.2008.00251.x. PMID 18266981.

79. "Sirtris Announces SRT501 Lowers Glucose in Twice-Daily Dosing Clinical Trial; Study Suggests Dose Response for Proprietary Formulation of Resveratrol in Type 2 Diabetics" (Press release). Sirtris Pharmaceuticals. April 17, 2008. Retrieved August 9, 2010.

80. "Sirtris Continues to Lead The Way In Resveratrol Based Research". My Resveratrol Experience. 2009-04-10. Retrieved 2011-01-22.

81. a b Marambaud P, Zhao H, Davies P (November 2005). "Resveratrol promotes clearance of Alzheimer's disease amyloid-beta peptides". J. Biol. Chem. 280 (45): 37377–82. doi:10.1074/jbc.M508246200. PMID 16162502.

82. Karuppagounder SS, Pinto JT, Xu H, Chen HL, Beal MF, Gibson GE (February 2009). "Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer's disease". Neurochem. Int. 54 (2): 111–8. doi:10.1016/j.neuint.2008.10.008. PMC 2892907. PMID 19041676.

83. Vingtdeux V, Giliberto L, Zhao H, Chandakkar P, Wu Q, Simon JE, Janle EM, Lobo J, Ferruzzi MG, Davies P, Marambaud P (March 2010). "AMP-activated protein kinase signaling activation by resveratrol modulates amyloid-beta peptide metabolism". J. Biol. Chem. 285 (12): 9100–1. doi:10.1074/jbc.M109.060061. PMID 20080969.

84. Anekonda TS (September 2006). "Resveratrol--a boon for treating Alzheimer's disease?". Brain Res Rev 52 (2): 316–26. doi:10.1016/j.brainresrev.2006.04.004. PMID 16766037.

85. Sharma M, Gupta YK (October 2002). "Chronic treatment with trans resveratrol prevents intracerebroventricular streptozotocin induced cognitive impairment and oxidative stress in rats". Life Sci. 71 (21): 2489–98. doi:10.1016/S0024-3205(02)02083-0. PMID 12270754.

86. Kumar P, Padi SS, Naidu PS, Kumar A (September 2006). "Effect of resveratrol on 3-nitropropionic acid-induced biochemical and behavioural changes: possible neuroprotective mechanisms". Behav Pharmacol 17 (5–6): 485–92. doi:10.1097/00008877-200609000-00014. PMID 16940769.

87. Yang YB, Piao YJ (July 2003). "Effects of resveratrol on secondary damages after acute spinal cord injury in rats". Acta Pharmacol. Sin. 24 (7): 703–10. PMID 12852839.

88. Sinha K, Chaudhary G, Gupta YK (June 2002). "Protective effect of resveratrol against oxidative stress in middle cerebral artery occlusion model of stroke in rats". Life Sci. 71 (6): 655–65. doi:10.1016/S0024-3205(02)01691-0. PMID 12072154.

89. Gentilli M, Mazoit JX, Bouaziz H, Fletcher D, Casper RF, Benhamou D, Savouret JF (February 2001). "Resveratrol decreases hyperalgesia induced by carrageenan in the rat hind paw". Life Sci. 68 (11): 1317–21. doi:10.1016/S0024-3205(00)01018-3. PMID 11233998.

90. Tsai SH, Lin-Shiau SY, Lin JK (February 1999). "Suppression of nitric oxide synthase and the down-regulation of the activation of NFkappaB in macrophages by resveratrol". Br. J. Pharmacol. 126 (3): 673–80. doi:10.1038/sj.bjp.0702357. PMC 1565862. PMID 10188978.

91. Elmali N, Baysal O, Harma A, Esenkaya I, Mizrak B (April 2007). "Effects of resveratrol in inflammatory arthritis". Inflammation 30 (1–2): 1–6. doi:10.1007/s10753-006-9012-0. PMID 17115116.

92.Docherty JJ, Fu MM, Stiffler BS, Limperos RJ, Pokabla CM, DeLucia AL (October 1999). "Resveratrol inhibition of herpes simplex virus replication". Antiviral Res. 43 (3): 145–55. doi:10.1016/S0166-3542(99)00042-X. PMID 10551373.

93. Docherty JJ, Fu MM, Hah JM, Sweet TJ, Faith SA, Booth T (September 2005). "Effect of resveratrol on herpes simplex virus vaginal infection in the mouse". Antiviral Res. 67 (3): 155–62. doi:10.1016/j.antiviral.2005.06.008. PMID 16125258.

94. Docherty JJ, Smith JS, Fu MM, Stoner T, Booth T (January 2004). "Effect of topically applied resveratrol on cutaneous herpes simplex virus infections in hairless mice". Antiviral Res. 61 (1): 19–26. doi:10.1016/j.antiviral.2003.07.001. PMID 14670590.

95. Docherty JJ, Sweet TJ, Bailey E, Faith SA, Booth T (December 2006). "Resveratrol inhibition of varicella-zoster virus replication in vitro". Antiviral Res. 72 (3): 171–7. doi:10.1016/j.antiviral.2006.07.004. PMID 16899306.

96. Guan WD, Yang ZF, Liu N, Qin S, Zhang FX, Zhu YT (September 2008). "[In vitro experimental study on the effect of resveratrol against several kinds of respiroviruses]". Zhong Yao Cai (in Chinese) 31 (9): 1388–90. PMID 19180966.

97. Palamara AT, Nencioni L, Aquilano K, De Chiara G, Hernandez L, Cozzolino F, Ciriolo MR, Garaci E (May 2005). "Inhibition of influenza A virus replication by resveratrol". J. Infect. Dis. 191 (10): 1719–29. doi:10.1086/429694. PMID 15838800.

98. Li YQ, Li ZL, Zhao WJ, Wen RX, Meng QW, Zeng Y (September 2006). "Synthesis of stilbene derivatives with inhibition of SARS coronavirus replication". Eur J Med Chem 41 (9): 1084–9. doi:10.1016/j.ejmech.2006.03.024. PMID 16875760.

99. Evers DL, Wang X, Huong SM, Huang DY, Huang ES (August 2004). "3,4',5-Trihydroxy-trans-stilbene (resveratrol) inhibits human cytomegalovirus replication and virus-induced cellular signaling". Antiviral Res. 63 (2): 85–95. doi:10.1016/j.antiviral.2004.03.002. PMID 15302137.

100. Heredia A, Davis C, Redfield R (November 2000). "Synergistic inhibition of HIV-1 in activated and resting peripheral blood mononuclear cells, monocyte-derived macrophages, and selected drug-resistant isolates with nucleoside analogues combined with a natural product, resveratrol". J. Acquir. Immune Defic. Syndr. 25 (3): 246–55.doi:10.1097/00126334-200011010-00006. PMID 11115955.

101. Shin S, Jeon JH, Park D, Jang MJ, Choi JH, Choi BH, Joo SS, Nahm SS, Kim JC, Kim YB (January 2008). "trans-Resveratrol relaxes the corpus cavernosum ex vivo and enhances testosterone levels and sperm quality in vivo". Arch. Pharm. Res. 31 (1): 83–7. doi:10.1007/s12272-008-1124-7. PMID 18277612.

102. Juan ME, González-Pons E, Munuera T, Ballester J, Rodríguez-Gil JE, Planas JM (April 2005). "trans-Resveratrol, a natural antioxidant from grapes, increases sperm output in healthy rats". J. Nutr. 135 (4): 757–60. PMID 15795430.

103. Yong Nam Han, Shi Yong Ryu, Byung Hoon Han. Antioxidant activity of resveratrol closely correlates with its monoamine oxidase-A inhibitory activity. Archives of Pharmacal Research. 1990;13(2):132–135. doi:10.1007/BF02857789.

104. http://www.mayoclinic.com/health/red-wine/HB00089

105. Asensi M, Medina I, Ortega A, Carretero J, Baño MC, Obrador E, Estrela JM (August 2002). "Inhibition of cancer growth by resveratrol is related to its low bioavailability". Free Radic. Biol. Med. 33 (3): 387–98. doi:10.1016/S0891-5849(02)00911-5. PMID 12126761.

106. Madhav NV, Shakya AK, Shakya P, Singh K (November 2009). "Orotransmucosal drug delivery systems: a review". J Control Release 140 (1): 2–11. doi:10.1016/j.jconrel.2009.07.016. PMID 19665039.

107. Ansari KA, Vavia PR, Trotta F, Cavalli R (March 2011). "Cyclodextrin-based nanosponges for delivery of resveratrol: in vitro characterisation, stability, cytotoxicity and permeation study". AAPS PharmSciTech 12 (1): 279–86. doi:10.1208/s12249-011-9584-3. PMC 3066340. PMID 21240574.

108. Shojaei AH (1998). "Buccal mucosa as a route for systemic drug delivery: a review". J Pharm Pharm Sci 1 (1): 15–30. PMID 10942969.

109. Santos AC, Veiga F, Ribeiro AJ (August 2011). "New delivery systems to improve the bioavailability of resveratrol". Expert Opin Drug Deliv 8 (8): 973–90. doi:10.1517/17425247.2011.581655. PMID 21668403.

110. Walle T, Hsieh F, DeLegge MH, Oatis JE, Walle UK (December 2004). "High absorption but very low bioavailability of oral resveratrol in humans". Drug Metab. Dispos. 32 (12): 1377–82. doi:10.1124/dmd.104.000885. PMID 15333514.

111. ClinicalTrials.gov NCT00920556

112. la Porte C, Voduc N, Zhang G, Seguin I, Tardiff D, Singhal N, Cameron DW (July 2010). "Steady-State pharmacokinetics and tolerability of trans-resveratrol 2000 mg twice daily with food, quercetin and alcohol (ethanol) in healthy human subjects". Clin Pharmacokinet 49 (7): 449–54. doi:10.2165/11531820-000000000-00000. PMID 20528005.

113. Marier JF, Vachon P, Gritsas A, Zhang J, Moreau JP, Ducharme MP (July 2002). "Metabolism and disposition of resveratrol in rats: extent of absorption, glucuronidation, and enterohepatic recirculation evidenced by a linked-rat model". J. Pharmacol. Exp. Ther. 302 (1): 369–73. doi:10.1124/jpet.102.033340. PMID 12065739.

114. Abd El-Mohsen M, Bayele H, Kuhnle G, Gibson G, Debnam E, Kaila Srai S, Rice-Evans C, Spencer JP (July 2006). "Distribution of [3H]trans-resveratrol in rat tissues following oral administration". Br. J. Nutr. 96 (1): 62–70. doi:10.1079/BJN20061810. PMID 16869992.

115. Yu C, Shin YG, Chow A, Li Y, Kosmeder JW, Lee YS, Hirschelman WH, Pezzuto JM, Mehta RG, van Breemen RB (December 2002). "Human, rat, and mouse metabolism of resveratrol". Pharm. Res. 19 (12): 1907–14. doi:10.1023/A:1021414129280. PMID 12523673.

116. Wang LX, Heredia A, Song H, Zhang Z, Yu B, Davis C, Redfield R (October 2004). "Resveratrol glucuronides as the metabolites of resveratrol in humans: characterization, synthesis, and anti-HIV activity". J Pharm Sci 93 (10): 2448–57. doi:10.1002/jps.20156. PMID 15349955.

117. Goldberg DM, Yan J, Soleas GJ (February 2003). "Absorption of three wine-related polyphenols in three different matrices by healthy subjects". Clin. Biochem. 36 (1): 79–87. doi:10.1016/S0009-9120(02)00397-1. PMID 12554065.

118. Wenzel E, Somoza V (May 2005). "Metabolism and bioavailability of trans-resveratrol". Mol Nutr Food Res 49 (5): 472–81. doi:10.1002/mnfr.200500010. PMID 15779070.

119. Vitaglione P, Sforza S, Galaverna G, Ghidini C, Caporaso N, Vescovi PP, Fogliano V, Marchelli R (May 2005). "Bioavailability of trans-resveratrol from red wine in humans". Mol Nutr Food Res 49 (5): 495–504. doi:10.1002/mnfr.200500002. PMID 15830336.

120. Corder R, Mullen W, Khan NQ, Marks SC, Wood EG, Carrier MJ, Crozier A (November 2006). "Oenology: red wine procyanidins and vascular health". Nature 444 (7119): 566. doi:10.1038/444566a. PMID 17136085.

121. Bowers JL, Tyulmenkov VV, Jernigan SC, Klinge CM (October 2000). "Resveratrol acts as a mixed agonist/antagonist for estrogen receptors alpha and beta". Endocrinology 141 (10): 3657–67. doi:10.1210/en.141.10.3657. PMID 11014220.

122. Levi F, Pasche C, Lucchini F, Ghidoni R, Ferraroni M, La Vecchia C (April 2005). "Resveratrol and breast cancer risk". Eur. J. Cancer Prev. 14 (2): 139–42. doi:10.1097/00008469-200504000-00009. PMID 15785317.

123. Garvin S, Ollinger K, Dabrosin C (January 2006). "Resveratrol induces apoptosis and inhibits angiogenesis in human breast cancer xenografts in vivo". Cancer Lett. 231 (1): 113–22. doi:10.1016/j.canlet.2005.01.031. PMID 16356836.

124. Bråkenhielm E, Cao R, Cao Y (August 2001). "Suppression of angiogenesis, tumor growth, and wound healing by resveratrol, a natural compound in red wine and grapes". FASEB J. 15 (10): 1798–800. doi:10.1096/fj.01-0028fje. PMID 11481234.

125. Leone S, Cornetta T, Basso E, Cozzi R (September 2010). "Resveratrol induces DNA double-strand breaks through human topoisomerase II interaction". Cancer Lett. 295 (2): 167–72. doi:10.1016/j.canlet.2010.02.022. PMID 20304553.

126. Jo JY, Gonzalez de Mejia E, Lila MA (March 2006). "Catalytic inhibition of human DNA topoisomerase II by interactions of grape cell culture polyphenols". J. Agric. Food Chem. 54 (6): 2083–7. doi:10.1021/jf052700z. PMID 16536579.

127. Paolini M, Sapone A, Valgimigli L (June 2003). "Avoidance of bioflavonoid supplements during pregnancy: a pathway to infant leukemia?". Mutat. Res. 527 (1–2): 99–101. doi:10.1016/S0027-5107(03)00057-5. PMID 12787918.

128. Alcaín FJ, Villalba JM (April 2009). "Sirtuin activators". Expert Opin Ther Pat 19 (4): 403–14. doi:10.1517/13543770902762893. PMID 19441923.

129. Kaeberlein M, Kirkland KT, Fields S, Kennedy BK (September 2004). "Sir2-independent life span extension by calorie restriction in yeast". PLoS Biol. 2 (9): E296. doi:10.1371/journal.pbio.0020296. PMC 514491. PMID 15328540.

130. Kaeberlein M, McDonagh T, Heltweg B, Hixon J, Westman EA, Caldwell SD, Napper A, Curtis R, DiStefano PS, Fields S, Bedalov A, Kennedy BK (April 2005). "Substrate-specific activation of sirtuins by resveratrol". J. Biol. Chem. 280 (17): 17038–45. doi:10.1074/jbc.M500655200. PMID 15684413.

131. Beher D, Wu J, Cumine S, Kim KW, Lu SC, Atangan L, Wang M (December 2009). "Resveratrol is not a direct activator of SIRT1 enzyme activity". Chem Biol Drug Des 74 (6): 619–24. doi:10.1111/j.1747-0285.2009.00901.x. PMID 19843076.

132. Pacholec M, Bleasdale JE, Chrunyk B, Cunningham D, Flynn D, Garofalo RS, Griffith D, Griffor M, Loulakis P, Pabst B, Qiu X, Stockman B, Thanabal V, Varghese A, Ward J, Withka J, Ahn K (March 2010). "SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1". J. Biol. Chem. 285 (11): 8340–51. doi:10.1074/jbc.M109.088682. PMC 2832984. PMID 20061378.

133. Robb EL, Page MM, Wiens BE, Stuart JA (March 2008). "Molecular mechanisms of oxidative stress resistance induced by resveratrol: Specific and progressive induction of MnSOD". Biochem. Biophys. Res. Commun. 367 (2): 406–12. doi:10.1016/j.bbrc.2007.12.138. PMID 18167310.

134. Radák, Zsolt (2000). Free radicals in exercise and aging. Champaign, IL: Human Kinetics. p. 39. ISBN 978-0-88011-881-1.

135. Macmillan-Crow LA, Cruthirds DL (April 2001). "Invited review: manganese superoxide dismutase in disease". Free Radic. Res. 34 (4): 325–36. doi:10.1080/10715760100300281. PMID 11328670.

136. Cullen JJ, Weydert C, Hinkhouse MM, Ritchie J, Domann FE, Spitz D, Oberley LW (March 2003). "The role of manganese superoxide dismutase in the growth of pancreatic adenocarcinoma". Cancer Res. 63 (6): 1297–303. PMID 12649190.

137. "Mounting evidence shows red wine antioxidant kills cancer" (Press release). University of Rochester Medical Center. March 26, 2008. Retrieved August 10, 2010.

138. Sun J, Folk D, Bradley TJ, Tower J (June 2002). "Induced overexpression of mitochondrial Mn-superoxide dismutase extends the life span of adult Drosophila melanogaster". Genetics 161 (2): 661–72. PMC 1462135. PMID 12072463.

139. Hu D, Cao P, Thiels E, Chu CT, Wu GY, Oury TD, Klann E (March 2007). "Hippocampal long-term potentiation, memory, and longevity in mice that overexpress mitochondrial superoxide dismutase". Neurobiol Learn Mem 87 (3): 372–84. doi:10.1016/j.nlm.2006.10.003. PMC 1847321. PMID 17129739.

140. Wong GH (May 1995). "Protective roles of cytokines against radiation: induction of mitochondrial MnSOD". Biochim. Biophys. Acta 1271 (1): 205–9. PMID 7599209.

141. Stefani M, Markus MA, Lin RC, Pinese M, Dawes IW, Morris BJ (October 2007). "The effect of resveratrol on a cell model of human aging". Ann. N. Y. Acad. Sci. 1114: 407–18. doi:10.1196/annals.1396.001. PMID 17804521.

142. Brunet A, Sweeney LB, Sturgill JF, Chua KF, Greer PL, Lin Y, Tran H, Ross SE, Mostoslavsky R, Cohen HY, Hu LS, Cheng HL, Jedrychowski MP, Gygi SP, Sinclair DA, Alt FW, Greenberg ME (March 2004). "Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase". Science 303 (5666): 2011–5. doi:10.1126/science.1094637. PMID 14976264.

143. Kops GJ, Dansen TB, Polderman PE, Saarloos I, Wirtz KW, Coffer PJ, Huang TT, Bos JL, Medema RH, Burgering BM (September 2002). "Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress". Nature 419 (6904): 316–21. doi:10.1038/nature01036. PMID 12239572.

144. Leiro J, Arranz JA, Fraiz N, Sanmartín ML, Quezada E, Orallo F (February 2005). "Effect of cis-resveratrol on genes involved in nuclear factor kappa B signaling". Int. Immunopharmacol. 5 (2): 393–406. doi:10.1016/j.intimp.2004.10.006. PMID 15652768.

145. Chun YJ, Kim MY, Guengerich FP (August 1999). "Resveratrol is a selective human cytochrome P450 1A1 inhibitor". Biochem. Biophys. Res. Commun. 262 (1): 20–4. doi:10.1006/bbrc.1999.1152. PMID 10448061.

146. Schwarz D, Roots I (April 2003). "In vitro assessment of inhibition by natural polyphenols of metabolic activation of procarcinogens by human CYP1A1". Biochem. Biophys. Res. Commun. 303 (3): 902–7. doi:10.1016/S0006-291X(03)00435-2. PMID 12670496.

147. Benitez DA, Pozo-Guisado E, Alvarez-Barrientos A, Fernandez-Salguero PM, Castellón EA (2007). "Mechanisms involved in resveratrol-induced apoptosis and cell cycle arrest in prostate cancer-derived cell lines". J. Androl. 28 (2): 282–93. doi:10.2164/jandrol.106.000968. PMID 17050787.

148. Faber AC, Chiles TC (December 2006). "Resveratrol induces apoptosis in transformed follicular lymphoma OCI-LY8 cells: evidence for a novel mechanism involving inhibition of BCL6 signaling". Int. J. Oncol. 29 (6): 1561–6. PMID 17088997.

149. Riles WL, Erickson J, Nayyar S, Atten MJ, Attar BM, Holian O (September 2006). "Resveratrol engages selective apoptotic signals in gastric adenocarcinoma cells". World J. Gastroenterol. 12 (35): 5628–34. PMID 17007014.

150. Sareen D, van Ginkel PR, Takach JC, Mohiuddin A, Darjatmoko SR, Albert DM, Polans AS (September 2006). "Mitochondria as the primary target of resveratrol-induced apoptosis in human retinoblastoma cells". Invest. Ophthalmol. Vis. Sci. 47 (9): 3708–16. doi:10.1167/iovs.06-0119. PMID 16936077.

151. Tang HY, Shih A, Cao HJ, Davis FB, Davis PJ, Lin HY (August 2006). "Resveratrol-induced cyclooxygenase-2 facilitates p53-dependent apoptosis in human breast cancer cells". Mol. Cancer Ther. 5 (8): 2034–42. doi:10.1158/1535-7163.MCT-06-0216. PMID 16928824.

152. Aziz MH, Nihal M, Fu VX, Jarrard DF, Ahmad N (May 2006). "Resveratrol-caused apoptosis of human prostate carcinoma LNCaP cells is mediated via modulation of phosphatidylinositol 3'-kinase/Akt pathway and Bcl-2 family proteins". Mol. Cancer Ther. 5 (5): 1335–41. doi:10.1158/1535-7163.MCT-05-0526. PMID 16731767.

153. Cao Y, Fu ZD, Wang F, Liu HY, Han R (June 2005). "Anti-angiogenic activity of resveratrol, a natural compound from medicinal plants". J Asian Nat Prod Res 7 (3): 205–13. doi:10.1080/10286020410001690190. PMID 15621628.

154. Hung LM, Chen JK, Huang SS, Lee RS, Su MJ (August 2000). "Cardioprotective effect of resveratrol, a natural antioxidant derived from grapes". Cardiovasc. Res. 47 (3): 549–55. doi:10.1016/S0008-6363(00)00102-4. PMID 10963727.

155. Parker JA, Arango M, Abderrahmane S, Lambert E, Tourette C, Catoire H, Néri C (April 2005). "Resveratrol rescues mutant polyglutamine cytotoxicity in nematode and mammalian neurons". Nat. Genet. 37 (4): 349–50. doi:10.1038/ng1534. PMID 15793589.

156. Olson ER, Naugle JE, Zhang X, Bomser JA, Meszaros JG (March 2005). "Inhibition of cardiac fibroblast proliferation and myofibroblast differentiation by resveratrol". Am. J. Physiol. Heart Circ. Physiol. 288 (3): H1131–8. doi:10.1152/ajpheart.00763.2004. PMID 15498824.

157. Bhat KP, Lantvit D, Christov K, Mehta RG, Moon RC, Pezzuto JM (October 2001). "Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models". Cancer Res. 61 (20): 7456–63. PMID 11606380.

158. Wang Y, Lee KW, Chan FL, Chen S, Leung LK (July 2006). "The red wine polyphenol resveratrol displays bilevel inhibition on aromatase in breast cancer cells". Toxicol. Sci. 92 (1): 71–7. doi:10.1093/toxsci/kfj190. PMID 16611627.

159. Kode A, Rajendrasozhan S, Caito S, Yang SR, Megson IL, Rahman I (March 2008). "Resveratrol induces glutathione synthesis by activation of Nrf2 and protects against cigarette smoke-mediated oxidative stress in human lung epithelial cells". Am. J. Physiol. Lung Cell Mol. Physiol. 294 (3): L478–88. doi:10.1152/ajplung.00361.2007. PMID 18162601.

160. Ghosh HS, McBurney M, Robbins PD (2010). "SIRT1 negatively regulates the mammalian target of rapamycin". In Blagosklonny, Mikhail V. PLoS ONE 5 (2): e9199. doi:10.1371/journal.pone.0009199. PMC 2821410. PMID 20169165.

161. Morselli E, Galluzzi L, Kepp O, Criollo A, Maiuri MC, Tavernarakis N, Madeo F, Kroemer G (December 2009). "Autophagy mediates pharmacological lifespan extension by spermidine and resveratrol". Aging (Albany NY) 1 (12): 961–70. PMC 2815753. PMID 20157579.

162. Tennen RI, Michishita-Kioi E, Chua KF (February 2012). "Finding a target for resveratrol". Cell 148 (3): 387–9. doi:10.1016/j.cell.2012.01.032. PMID 22304906.

163. Park SJ, Ahmad F, Philp A, Baar K, Williams T, Luo H, Ke H, Rehmann H, Taussig R, Brown AL, Kim MK, Beaven MA, Burgin AB, Manganiello V, Chung JH (February 2012). "Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases". Cell 148 (3): 421–33. doi:10.1016/j.cell.2012.01.017. PMID 22304913.

164. Kenichi Mizutani, Katsumi Ikeda, Yukio Yamori (2000). "Resveratrol Inhibits AGEs-Induced Proliferation and Collagen Synthesis Activity in Vascular Smooth Muscle Cells from Stroke-Prone Spontaneously Hypertensive Rats". Biochemical and Biophysical Research Communications 274 (1): 61–67. doi:10.1006/bbrc.2000.3097. PMID 10903896.

165. Mattivi F, Reniero F, Korhammer S (1995). "Isolation, characterization, and evolution in red wine vinification of resveratrol monomers". J Agric Food Chem. 43 (7): 1820–3. doi:10.1021/jf00055a013.

166. Lamuela-Raventos RM, Romero-Perez AI, Waterhouse AL, de la Torre-Boronat MC (1995). "Direct HPLC Analysis of cis- and trans-Resveratrol and Piceid Isomers in Spanish Red Vitis vinifera Wines". Journal of Agricultural and Food Chemistry 43 (2): 281–283. doi:10.1021/jf00050a003.

167. Resveratrol Photoisomerization: An Integrative Guided-Inquiry Experiment Elyse Bernard, Philip Britz-McKibbin, Nicholas Gernigon Vol. 84 No. 7 July 2007 Journal of Chemical Education 1159.

168. Prokop J, Abrman P, Seligson AL, Sovak M (2006). "Resveratrol and its glycon piceid are stable polyphenols". J Med Food 9 (1): 11–4. doi:10.1089/jmf.2006.9.11. PMID 16579722.

169. Bertelli AA, Gozzini A, Stradi R, Stella S, Bertelli A (1998). "Stability of resveratrol over time and in the various stages of grape transformation". Drugs Exp Clin Res 24 (4): 207–11. PMID 10051967.

170.Schroder, Gudrun; John W. S. Brown and Joachim Schroder (1988). "Molecular analysis of resveratrol synthase cDNA, genomic clones and relationship with chalcone synthase". European Journal of Biochemistry 172 (1): 161–169.

171. Cichewicz, RH; Kouzi, SA; Hamann, MT (2000). "Dimerization of resveratrol by the grapevine pathogen Botrytis cinerea". Journal of Natural Products 63 (1): 29–33. PMID 10650073.

172. Cichewicz, RH; Kouzi, SA (1998). "Biotransformation of resveratrol to piceid by Bacillus cereus". Journal of Natural Products 61 (10): 1313–4. doi:10.1021/np980139b. PMID 9784180.

173."The role of grape polyphenols on trans-resveratrol activity against Botrytis cinerea and of fungal laccase on the solubility of putative grape PR proteins, F. Favaron, M. Lucchetta, S. Odorizzi, A.T. Pais da Cunha and L. Sella, Journal of Plant Pathology (2009), 91 (3), 579–588, 2009 579" (PDF). Retrieved 2011-01-22.

174. Gatto P, Vrhovsek U, Muth J, Segala C, Romualdi C, Fontana P, Pruefer D, Stefanini M, Moser C, Mattivi F, Velasco R (December 2008). "Ripening and genotype control stilbene accumulation in healthy grapes". J. Agric. Food Chem. 56 (24): 11773–85. doi:10.1021/jf8017707. PMID 19032022.

175. Roy, H., Lundy, S., Resveratrol, Pennington Nutrition Series, 2005 No. 7

176. LeBlanc, Mark Rene (13 December 2005). "Cultivar, Juice Extraction, Ultra Violet Irradiation and Storage Influence the Stilbene Content of Muscadine Grapes (Vitis Rotundifolia Michx.)". Retrieved 2007-08-15.

177. Gu X, Creasy L, Kester A, Zeece M (August 1999). "Capillary electrophoretic determination of resveratrol in wines". J. Agric. Food Chem. 47 (8): 3223–7. doi:10.1021/jf981211e. PMID 10552635.

178. Mattivi F (June 1993). "Solid phase extraction of trans-resveratrol from wines for HPLC analysis". Z Lebensm Unters Forsch 196 (6): 522–5. doi:10.1007/BF01201331. PMID 8328217.

179. Ector BJ, Magee JB, Hegwood CP, Coign MJ., Resveratrol Concentration in Muscadine Berries, Juice, Pomace, Purees, Seeds, and Wines.

180. Pastrana-Bonilla E, Akoh CC, Sellappan S, Krewer G (August 2003). "Phenolic content and antioxidant capacity of muscadine grapes". J. Agric. Food Chem. 51 (18): 5497–503. doi:10.1021/jf030113c. PMID 12926904. "Contrary to previous results, ellagic acid and not resveratrol was the major phenolic in muscadine grapes. The HPLC solvent system used coupled with fluorescence detection allowed separation of ellagic acid from resveratrol and detection of resveratrol." "[T]rans-resveratrol had the lowest concentrations of the detected phenolics, ranging from not detected in two varieties to 0.2 mg/ 100 g of FW (Tables 1 and 2). Our result for resveratrol differed from previous results [Ector et al., 1996] indicating high concentrations. These researchers apparently were not able to separate ellagic acid from resveratrol with UV detection alone."

181. Hudson TS, Hartle DK, Hursting SD, Nunez NP, Wang TT, Young HA, Arany P, Green JE (September 2007). "Inhibition of prostate cancer growth by muscadine grape skin extract and resveratrol through distinct mechanisms". Cancer Res. 67 (17): 8396–405. doi:10.1158/0008-5472.CAN-06-4069. PMID 17804756. "MSKE [muscadine grape skin extract] does not contain significant quantities of resveratrol and differs from MSEE. To determine whether MSKE contains significant levels of resveratrol and to compare the chemical content of MSKE (skin) with MSEE (seed), HPLC analyses were done. As depicted in Supplementary Fig. S1A and B, MSKE does not contain significant amounts of resveratrol (<1 ?g/g by limit of detection)."

182. Wang KH, Lai YH, Chang JC, Ko TF, Shyu SL, Chiou RY (January 2005). "Germination of peanut kernels to enhance resveratrol biosynthesis and prepare sprouts as a functional vegetable". J. Agric. Food Chem. 53 (2): 242–6. doi:10.1021/jf048804b. PMID 15656656.

183. Stewart JR, Artime MC, O'Brian CA (July 2003). "Resveratrol: a candidate nutritional substance for prostate cancer prevention". J. Nutr. 133 (7 Suppl): 2440S–2443S. PMID 12840221.

184. Hurst WJ, Glinski JA, Miller KB, Apgar J, Davey MH, Stuart DA (September 2008). "Survey of the trans-resveratrol and trans-piceid content of cocoa-containing and chocolate products". J. Agric. Food Chem. 56 (18): 8374–8. doi:10.1021/jf801297w. PMID 18759443.

185. Mozzon M (1996). "Resveratrol content in some Tuscan wines". Ital. J. Food Sci. (Chiriotti, Pinerolo, ITALIE) 8 (2): 145–52. Retrieved 2007-06-18.

186. Stervbo U, Vang O, Bonnesen C (2007). "A review of the content of the putative chemopreventive phytoalexin resveratrol in red wine". Food Chemistry 101 (2): 449–57. doi:10.1016/j.foodchem.2006.01.047.

187. Higdon, Jane; Drake, Victoria J.; Steward, William P. (May 2008). "Resveratrol". Micronutrient Information Center. Linus Pauling Institute.

188. (1999). "Resveratrol In Peanuts". Kids Food for Thought (The Peanut Institute) 1 (4). Archived from the original on August 24, 2000.[unreliable source?]

189. Wang Y, Catana F, Yang Y, Roderick R, van Breemen RB (January 2002). "An LC-MS method for analyzing total resveratrol in grape juice, cranberry juice, and in wine". J. Agric. Food Chem. 50 (3): 431–5. doi:10.1021/jf010812u. PMID 11804508.

190. Lyons MM, Yu C, Toma RB, Cho SY, Reiboldt W, Lee J, van Breemen RB (September 2003). "Resveratrol in raw and baked blueberries and bilberries". J. Agric. Food Chem. 51 (20): 5867–70. doi:10.1021/jf034150f. PMID 13129286.

191. Rimas A (2006 -12-11). "His research targets the aging process". The Boston Globe.

192. Stipp D (2007-01-19). "Can red wine help you live forever?". Fortune magazine.

193. Seward ZM (2006-11-30). "Quest for youth drives craze for 'wine' pills". The Wall Street Journal.

194. "Caution urged with resveratrol". United Press International. November 30, 2006-11-30.

195. Aleccia J (2008-04-22). "Longevity quest moves slowly from lab to life". MSNBC.

196. Gocze T (2008-09-08). "Japanese Knotweed a Resilient Invader". Bangor Daily News. 197. Weintraub A (2009-07-29). "Resveratrol: The Hard Sell on Anti-Aging". Bloomberg Businessweek.

198. Biotransformation of mulberroside A from Morus alba results in enhancement of tyrosinase inhibition. Jeong-Keun Kim, Mijin Kim, Ssang-Goo Cho, Myung-Kyoo Kim, Suhng Kim and Young-Hee Lim, Journal of Industrial Microbiology & Biotechnology, Jun 2010, Vol. 37, Issue 6, page 631, PubMed

199. http://www.naturalnews.com/041507_melanoma_resveratrol_red_wine.html

200. Antibacterial phenolics from Boswellia dalzielii. Alemika Taiwo E, Onawunmi Grace O and Olugbade Tiwalade O, Nigerian Journal of Natural Products and Medicines, 2006 (abstract)


  • 43 Units in Stock
  • Manufactured for: Z Natural Foods


DMCA.com Protection Status Authorize.Net Merchant - Click to Verify
 


The products, claims, reviews, & testimonials made about products & services on or through this site have not been evaluated by Z Natural Foods, LLC. or the U.S. Food and Drug Administration & are not intended to diagnose, treat, cure, or prevent any disease or medical condition. The information provided on this site & any information contained on or in any product label or packaging is for informational purposes only & is not intended as a substitute for advice from your physician or other health care professional. You should not use the information on this site for diagnosis or treatment of any health problem or for prescription of any medication or other treatment. You should consult with a healthcare professional before using any of our products, starting any diet, exercise, supplementation program, taking any medication, or if you have or suspect you might have a health problem or have a family history of health problems. Individual results may vary. Z Natural Foods urges you to seek the advice of a qualified professional for any health concern lasting more than two weeks, & to share with your provider any information pertaining to your health & well-being, including the use of supplemental nutrition. You should not stop taking any medications without first consulting your physician. Use of the Z Natural Foods website & Services is governed by our Terms & Conditions, Privacy Policy, & Disclaimer.

 

Copyright © 2016 Z Natural Foods, LLC.